The Need for a Prophylactic Gastrojejunostomy for Unresectable Periampullary Cancer: A Prospective Randomized Multicenter Trial with Special Focus on Assessment of Quality of Life

Annals of Surgery

Volumn 238, Issue 6, 2003, Pages 894-905

  Van Heek, N Tjarda ^a   De Castro, Steve M M ^a   Van Eijck, Casper H ^c   Van Geenen, Rutger C I ^b   Hesselink, Eric J ^d   Breslau, Paul J ^e   Tran, T C Khe ^c   Kazemier, Geert ^c   Visser, Mechteld R M ^a   Busch, Olivier R C ^a   Obertop, Hugo ^a   Gouma, Dirk J ^a   Fingerhut, A ^f,f   Neuhaus, P ^f   Fernandez Cruz, L ^f   Russell, R C G ^f   Johnson, A G ^f   Buchler, M W ^f   Morino, M ^f   Gooszen, H G ^f  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b ONZE LIEVE VROUWE GASTHUIS   (Netherlands)

^c ERASMUS MEDICAL CENTER   (Netherlands)

^d GELRE HOSPITALS   (Netherlands)

^e Red Cross Hospital Den Haag   (Netherlands)

^f NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; BILE DUCT CARCINOMA; CANCER SURGERY; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; GASTROINTESTINAL CARCINOMA; GASTROJEJUNOSTOMY; HEPATOJEJUNOSTOMY; HOSPITALIZATION; HUMAN; INTESTINE OBSTRUCTION; LAPAROTOMY; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; METASTASIS; MORBIDITY; MORTALITY; MULTICENTER STUDY; PANCREAS CARCINOMA; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROPHYLAXIS; PROSPECTIVE STUDY; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; REOPERATION; RISK REDUCTION; SCORING SYSTEM; SURGICAL APPROACH; SURGICAL TECHNIQUE; SURVIVAL; SYMPTOMATOLOGY; VATER PAPILLA CARCINOMA; ARTICLE; BILE DUCT TUMOR; GASTROSTOMY; JEJUNOSTOMY; MIDDLE AGED; SURVIVAL RATE; VATER PAPILLA;

AGED; AMPULLA OF VATER; COMMON BILE DUCT NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; GASTROSTOMY; HUMANS; JEJUNOSTOMY; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; QUALITY OF LIFE; SURVIVAL RATE;

EID: 0842332334     PISSN: 00034932     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.sla.0000098617.21801.95     Document Type: Conference Paper

References (51)

1. Singh SM, Longmire WP Jr, Reber HA. Surgical palliation for pancreatic cancer: the UCLA experience. Ann Surg. 1990;212:132-139.
2. Warshaw AL, Gu ZY, Wittenberg J, et al. Preoperative staging and assessment of resectability of pancreatic cancer. Arch Surg. 1990;125:230-233.
3. Sohn TA, Lillemoe KD, Cameron JL, et al. Surgical palliation of unresectable periampullary adenocarcinoma in the 1990s. J Am Coll Surg. 1999;188:658-666; discussion 666-669.
4. van Heek NT, van Geenen RC, Busch OR, et al. Palliative treatment in "peri"-pancreatic carcinoma: stenting or surgical therapy? Acta Gastroenterol Belg. 2002;65:171-175.
5. Russell RC. Palliation of pain and jaundice: an overview. Ann Oncol. 1999;10(suppl 4):165-169.
6. Urbach DR, Bell CM, Swanstrom LL, et al. Cohort study of surgical bypass to the gallbladder or bile duct for the palliation of jaundice due to pancreatic cancer. Ann Surg. 2003;237:86-93.
7. van den Bosch RP, van der Schelling GP, Klinkenbijl JH, et al. Guidelines for the application of surgery and endoprostheses in the palliation of obstructive jaundice in advanced cancer of the pancreas. Ann Surg. 1994;219:18-24.
8. Sarr MG, Cameron JL. Surgical management of unresectable carcinoma of the pancreas. Surgery. 1982;91:123-133.
9. Watanapa P, Williamson RC. Surgical palliation for pancreatic cancer: developments during the past two decades. Br J Surg. 1992;79:8-20.
10. Nieveen van Dijkum EJ, Romijn MG, Terwee CB, et al. Laparoscopic staging and subsequent palliation in patients with peripancreatic carcinoma. Ann Surg. 2003;237:66-73.
11. Lillemoe KD, Cameron JL, Hardacre JM, et al. Is prophylactic gastrojejunostomy indicated for unresectable periampullary cancer? A prospective randomized trial. Ann Surg. 1999;230:322-328; discussion 328-330.
12. Sohn TA, Yeo CJ, Cameron JL, et al. Resected adenocarcinoma of the pancreas-616 patients: results, outcomes, and prognostic indicators. J Gastrointest Surg. 2000;4:567-579.
13. van Wagensveld BA, Coene PP, van Gulik TM, et al. Outcome of palliative biliary and gastric bypass surgery for pancreatic head carcinoma in 126 patients. Br J Surg. 1997;84:1402-1406.
14. van der Schelling GP, van den Bosch RP, Klinkenbij JH, et al. Is there a place for gastroenterostomy in patients with advanced cancer of the head of the pancreas? World J Surg. 1993;17:128-132; discussion 132-133.
15. de Haes J, Curran D, Young T, et al. Quality of life evaluation in oncological clinical trials-the EORTC model: the EORTC Quality of Life Study Group Quality-of-life assessment in oncology. Achievements and challenges. Eur J Cancer. 2000;36:821-825.
16. Sprangers MA. Quality-of-life assessment in oncology: achievements and challenges. Acta Oncol. 2002;41:229-237.
17. Blazeby JM, Vickery CW. Quality of life in patients with cancers of the upper gastrointestinal tract. Expert Rev Anticancer Ther. 2001;1:269-276.
18. Smith AC, Dowsett JF, Russell RC, et al. Randomised trial of endoscopic stenting versus surgical bypass in malignant low bile duct obstruction. Lancet. 1994;344:1655-1660.
19. Yeo CJ, Barry MK, Sauter PK, et al. Erythromycin accelerates gastric emptying after pancreaticoduodenectomy: a prospective, randomized, placebo-controlled trial. Ann Surg. 1993;218:229-237; discussion 237-238.
20. Aaronson NK, Ahmedzai S, Bergman B, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993;85:365-376.
21. Sprangers MA, Cull A, Groenvold M, et al. The European Organization for Research and Treatment of Cancer approach to developing questionnaire modules: an update and overview: EORTC Quality of Life Study Group. Qual Life Res. 1998;7:291-300.
22. Bjordal K, Kaasa S. Psychometric validation of the EORTC Core Quality of Life Questionnaire, 30-item version and a diagnosis-specific module for head and neck cancer patients. Acta Oncol. 1992;31:311-321.
23. Osoba D, Zee B, Pater J, et al. Psychometric properties and responsiveness of the EORTC quality of Life Questionnaire (QLQ-C30) in patients with breast, ovarian and lung cancer. Qual Life Res. 1994;3:353-364.
24. Schwarz R, Hinz A. Reference data for the quality of life questionnaire EORTC QLQ-C30 in the general German population. Eur J Cancer. 2001;37:1345-1351.
25. Fitzsimmons D, Johnson CD, George S, et al. Development of a disease specific quality of life (QoL) questionnaire module to supplement the EORTC core cancer QoL questionnaire, the QLQ-C30 in patients with pancreatic cancer. EORTC Study Group on Quality of Life. Eur J Cancer. 1999;35:939-941.
26. EORTC. EORTC QLQ-C30 Manual. Brussels: EORTC, 2001.
27. Morris IN, Suissa S, Sherwood S, et al. Last days: a study of the quality of life of terminally ill cancer patients. J Chronic Dis. 1986;39:47-62.
28. Morris IN, Sherwood S. Quality of life of cancer patients at different stages in the disease trajectory. J Chronic Dis. 1987;40:545-556.
29. Keymling M, Wagner HJ, Vakil N, et al. Relief of malignant duodenal obstruction by percutaneous insertion of a metal stent. Gastrointest Endosc. 1993;39:439-441.
30. Maetani I, Tada T, Shimura J, et al. Technical modifications and strategies for stenting gastric outlet strictures using esophageal endoprostheses. Endoscopy. 2002;34:402-406.
31. Adam A, Chetty N, Roddie M, et al. Self-expandable stainless steel endoprostheses for treatment of malignant bile duct obstruction. AJR Am J Roentgenol. 1991;156:321-325.
32. Tham TC, Lichtenstein DR, Vandervoort J, et al. Pancreatic duct stents for "obstructive type" pain in pancreatic malignancy. Am J Gastroenterol. 2000;95:956-960.
33. Gentileschi P, Kini S, Gagner M. Palliative laparoscopic hepatico- and gastrojejunostomy for advanced pancreatic cancer. JSLS. 2002;6:331-338.
34. Parks RW, Johnston GW, Rowlands BJ. Surgical biliary bypass for benign and malignant extrahepatic biliary tract disease. Br J Surg. 1997;84:488-492.
35. Gouma DJ, van Geenen R, van Gulik T, et al. Surgical palliative treatment in bilio-pancreatic malignancy. Ann Oncol. 1999;10(suppl 4):269-272.
36. van Geenen RC, Keyzer-Dekker CM, van Tienhoven G, et al. Pain management of patients with unresectable peripancreatic carcinoma. World J Surg. 2002;26:715-720.
37. Redmond HP, Stuart R, Hofmann KP, et al. Carcinoma of the head of the pancreas. Surg Gynecol Obstet. 1991;172:186-190.
38. Singh SM, Reber HA. Surgical palliation for pancreatic cancer. Surg Clin North Am. 1989;69:599-611.
39. Weaver DW, Wiencek RG, Bouwman DL, et al. Gastrojejunostomy: is it helpful for patients with pancreatic cancer? Surgery. 1987;102:608-613.
40. Schantz SP, Schickler W, Evans TK, et al. Palliative gastroenterostomy for pancreatic cancer. Am J Surg. 1984;147:793-796.
41. Egrari S, O'Connell TX. Role of prophylactic gastroenterostomy for unresectable pancreatic carcinoma. Am Surg. 1995;61:862-864.
42. de Rooij PD, Rogatko A, Brennan MF. Evaluation of palliative surgical procedures in unresectable pancreatic cancer. Br J Surg. 1991;78:1053-1058.
43. Wagner M, Egger B, Kulli C, et al. Stent or surgical bypass as palliative therapy in obstructive jaundice. Swiss Surg. 2000;6:283-288.
44. Shyr YM, Su CH, Wu CW, et al. Prospective study of gastric outlet obstruction in unresectable periampullary adenocarcinoma. World J Surg. 2000;24:60-64; discussion 64-65.
45. Heinicke JM, Buchler MW, Laffer UT. Bilio-digestive double bypass for nonresectable pancreatic cancer. Dig Surg. 2002;19:165-167.
46. Potts JR 3rd, Broughan TA, Hermann RE. Palliative operations for pancreatic carcinoma. Am J Surg. 1990;159:72-77; discussion 77-78.
47. Terwee CB, Nieveen Van Dijkum EJ, Gouma DJ, et al. Pooling of prognostic studies in cancer of the pancreatic head and periampullary region: the Triple-P study. Triple-P study group. Eur J Surg. 2000;166:706-712.
48. Velanovich V. Using quality-of-life instruments to assess surgical outcomes. Surgery. 1999;126:1-4.
49. Fayers P, Bottomley A. Quality of life research within the EORTC-the EORTC QLQ-C30: European Organisation for Research and Treatment of Cancer. Eur J Cancer. 2002;38(suppl 4):125-133.
50. Machin D, Weeden S. Suggestions for the presentation of quality of life data from clinical trials. Stat Med. 1998;17:711-724.
51. Hopwood P, Stephens RJ, Machin D. Approaches to the analysis of quality of life data: experiences gained from a medical research council lung cancer working party palliative chemotherapy trial. Qual Life Res. 1994;3:339-352.